Patents by Inventor Wayne Schneider
Wayne Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170299549Abstract: A separation module operates to fractionate or separate an analyte into fractions according to pI, i.e., pI bands, utilizing capillary isoelectric focusing (“CIEF”) within a first microchannel. The fractions are stacked to form plugs, the number of which is determined by a number of parallel second microchannels integrally connected to the first microchannel, into which the fractions are directed according to the buffer characteristics found in each of the individual microchannels. Within the microchannels the plugs are separated into proteins according to a different chemical property, i.e., “m/z,” utilizing capillary electrophoresis (“CE”).Type: ApplicationFiled: July 3, 2017Publication date: October 19, 2017Applicants: Leidos, Inc., Georgetown UniversityInventors: Thomas Wayne Schneider, James N. Baraniuk
-
Patent number: 9778223Abstract: A separation module operates to fractionate or separate an analyte into fractions according to pI, i.e., pI bands, utilizing capillary isoelectric focusing (“CIEF”) within a first microchannel. The fractions are stacked to form plugs, the number of which is determined by a number of parallel second microchannels integrally connected to the first microchannel, into which the fractions are directed according to the buffer characteristics found in each of the individual microchannels. Within the microchannels the plugs are separated into proteins according to a different chemical property, i.e., “m/z,” utilizing capillary electrophoresis (“CE”).Type: GrantFiled: September 25, 2014Date of Patent: October 3, 2017Assignee: Leidos, Inc.Inventors: Thomas Wayne Schneider, James N. Baraniuk
-
Patent number: 9694021Abstract: The present invention is related to pharmaceutical compositions that include a phosphonium antimicrobial agent. In a preferred embodiment, the present invention relates to an otic, nasal or ophthalmic composition (e.g., an aqueous ophthalmic solution) that includes a phosphonium salt compound as an antimicrobial agent. The compositions typically possess sufficient antimicrobial activity to satisfy USP preservative efficacy requirements and/or similar preservative standards (e.g., EP and JP).Type: GrantFiled: November 20, 2013Date of Patent: July 4, 2017Assignee: ALCON RESEARCH, LTDInventors: Masood A. Chowhan, Wesley Wehsin Han, L. Wayne Schneider
-
Publication number: 20160005230Abstract: The invention provides for topical, relevant content to be delivered from a central server to devices running a viewer application. The content can be customized using the current user, device, location, compass, accelerometer and date/time information. The viewer application scans for known targets using its camera, or an end-user can make a selection from a text or visual directory. Once found, the platform is notified of the target. The platform then sends the appropriately customized content and data on how to render said content to the viewer for display, which can be text, images, data, video, animation, notifications and other types of content. The platform uses a data warehouse to refine content and provide detailed analytics. The platform can provide automatic content at launch. The viewer caches data for optimal performance. The user can respond to content, which delivers analytics, and more content as appropriate.Type: ApplicationFiled: July 3, 2014Publication date: January 7, 2016Inventors: Randy Pete Asselin, David Wayne Schneider
-
Publication number: 20150209466Abstract: The use of certain synthetic phospholipids to preserve pharmaceutical compositions from microbial contamination is described. The synthetic phospholipids have unique molecular arrangements wherein a phosphate group is linked to a quaternary ammonium functionality via a substituted-propenyl group, and the quaternary ammonium functionality is further linked to at least one long hydrocarbon chain. Such molecular arrangements are what make the phospholipids of formula (I) highly water soluble, e.g., the length of the hydrocarbon chain assists to maintain solubility and efficacy of the molecules for the uses described herein. The synthetic phospholipids described herein have been found to be particularly useful as antimicrobial preservatives for ophthalmic, otic and nasal pharmaceutical compositions, especially ophthalmic compositions. These compounds may also be utilized to disinfect contact lenses.Type: ApplicationFiled: February 19, 2015Publication date: July 30, 2015Applicant: ALCON RESEARCH, LTD.Inventors: Malay Ghosh, Masood A. Chowhan, L. Wayne Schneider
-
Publication number: 20150008130Abstract: A separation module operates to fractionate or separate an analyte into fractions according to pI, i.e., pI bands, utilizing capillary isoelectric focusing (“CIEF”) within a first microchannel. The fractions are stacked to form plugs, the number of which is determined by a number of parallel second microchannels integrally connected to the first microchannel, into which the fractions are directed according to the buffer characteristics found in each of the individual microchannels. Within the microchannels the plugs are separated into proteins according to a different chemical property, i.e., “m/z,” utilizing capillary electrophoresis (“CE”).Type: ApplicationFiled: September 25, 2014Publication date: January 8, 2015Inventors: Thomas Wayne Schneider, James N. Baraniuk
-
Patent number: 8859296Abstract: A separation module operates to fractionate or separate an analyte into fractions according to pI, i.e., pI bands, utilizing capillary isoelectric focusing (“CIEF”) within a first microchannel. The fractions are stacked to form plugs, the number of which is determined by a number of parallel second microchannels integrally connected to the first microchannel, into which the fractions are directed according to the buffer characteristics found in each of the individual microchannels. Within the microchannels the plugs are separated into proteins according to a different chemical property, i.e., “m/z,” utilizing capillary electrophoresis (“CE”).Type: GrantFiled: December 12, 2011Date of Patent: October 14, 2014Assignees: Leidos, Inc., Georgetown UniversityInventors: Thomas Wayne Schneider, James N. Baraniuk
-
Publication number: 20140107121Abstract: The invention provides solution compositions comprising olopatadine and a PDE4 inhibitor compound of Formula I: The invention also provides methods for treating allergic and inflammatory diseases. More particularly, the present invention relates to formulations of olopatadine and their use for treating and/or preventing allergic or inflammatory disorders of the eye, nose, skin, and ear.Type: ApplicationFiled: December 17, 2013Publication date: April 17, 2014Applicant: Alcon Research, Ltd.Inventors: L. Wayne Schneider, Wesley Wehsin Han, Masood A. Chowhan
-
Publication number: 20140080793Abstract: The present invention is related to pharmaceutical compositions that include a phosphonium antimicrobial agent. In a preferred embodiment, the present invention relates to an otic, nasal or ophthalmic composition (e.g., an aqueous ophthalmic solution) that includes a phosphonium salt compound as an antimicrobial agent. The compositions typically possess sufficient antimicrobial activity to satisfy USP preservative efficacy requirements and/or similar preservative standards (e.g., EP and JP).Type: ApplicationFiled: November 20, 2013Publication date: March 20, 2014Applicant: Alcon Research, Ltd.Inventors: Masood A. Chowhan, Wesley Wehsin Han, L. Wayne Schneider
-
Publication number: 20140016938Abstract: A tunable channel transmitter system for a wavelength division multiplexed (WDM) passive optical network (PON) includes a WDM communication system having a plurality of WDM channel bandwidths, an injection-locked Fabry-Perot laser having a plurality of resonant modes, a seed light source to provide seed light to the injection-locked Fabry-Perot laser, and a temperature control element configured to shift the plurality of resonant modes of the injection-locked Fabry-Perot laser to ensure that only one resonant mode of the injection-locked Fabry-Perot laser is locked to the seed source and transmitting a substantial portion of the laser power through a desired channel of the WDM communications system.Type: ApplicationFiled: July 11, 2012Publication date: January 16, 2014Applicant: ADTRAN, INC.Inventors: Leif J. Sandstrom, Kevin Wayne Schneider
-
Publication number: 20130119217Abstract: There is provided a device for hanging an object on a wall. The device includes a wall mount and an object mount. One mount has first and second bracket portions each being u-shaped and configured to receive the other mount. Each bracket portion has a horizontally-extending elongated slot. The other mount has a projection shaped to extend through the slots. The projection limits horizontal movement of the object mount relative to the wall mount to within a set range. The set range spans a first position where the projection abuts a part of the first bracket portion adjacent to a distal end of its elongated slot, to a second position, where the projection abuts a part of the second bracket portion adjacent to a distal end of its elongated slot. The wall mount may include a vertically-extending slot for vertical adjustment of the device relative to the wall.Type: ApplicationFiled: January 4, 2013Publication date: May 16, 2013Inventor: Timothy Wayne Schneider
-
Patent number: 8371543Abstract: There is provided a device for hanging an object on a wall. The device includes a wall mount and an object mount. One mount has a first bracket portion and a second bracket portion each being u-shaped and configured to receive the other mount. The bracket portions have a space between the bracket portions. The other mount has a projection disposable in the space between the bracket portions. The projection also acts as a safety tab. The bracket portions enable horizontal positioning of the object mount relative to the wall mount to be adjustable. The projection is configured to interact with the bracket portions and limit horizontal movement of the object mount relative to the wall mount to within a set range spanning the space from a first position, where the projection abuts the first bracket portion, to a second position where the projection abuts the second bracket portion.Type: GrantFiled: December 16, 2010Date of Patent: February 12, 2013Inventor: Timothy Wayne Schneider
-
Patent number: 8323630Abstract: The present invention is directed to the provision of multi-dose, self-preserved ophthalmic compositions. The compositions possess sufficient antimicrobial activity to satisfy USP preservative efficacy requirements, as well as similar preservative standards (e.g., EP and JP), without requiring the presence of conventional anti-microbial preservative agents, such as benzalkonium chloride. The compositions are effectively preserved by a balanced ionic buffer system containing zinc ions at a concentration of 0.04 to 0.9 mM, preferably 0.04 to 0.4 mM. One aspect of the balanced buffer system is limitation of the amount of buffering anions present to a concentration of 15 mM or less, preferably 5 mM or less. In a preferred embodiment, the compositions also contain borate or, most preferably, one or more borate/polyol complexes. The use of propylene glycol as the polyol in such complexes is strongly preferred.Type: GrantFiled: April 14, 2011Date of Patent: December 4, 2012Assignee: Alcon Research, Ltd.Inventors: Bhagwati P. Kabra, Masood A. Chowhan, L. Wayne Schneider, Wesley Wehsin Han
-
Patent number: 8268299Abstract: The present invention is directed to the provision of multi-dose, self-preserved ophthalmic compositions. The compositions possess sufficient antimicrobial activity to satisfy USP preservative efficacy requirements, as well as similar preservative standards (e.g., EP and JP), without requiring the presence of conventional anti-microbial preservative agents, such as benzalkonium chloride. The compositions are effectively preserved by a balanced ionic buffer system containing zinc ions at a concentration of 0.04 to 0.9 mM, preferably 0.04 to 0.4 mM. One aspect of the balanced buffer system is limitation of the amount of buffering anions present to a concentration of 15 mM or less, preferably 5 mM or less. In a preferred embodiment, the compositions also contain borat or, most preferably, one or more borate/polyol complexes. The use of propylene glycol as the polyol in such complexes is strongly preferred.Type: GrantFiled: September 20, 2007Date of Patent: September 18, 2012Assignee: Alcon Research, Ltd.Inventors: Bhagwati P. Kabra, Masood A. Chowhan, L. Wayne Schneider, Wesley Wehsin Han
-
Publication number: 20120153108Abstract: There is provided a device for hanging an object on a wall. The device includes a wall mount and an object mount. One mount has a first bracket portion and a second bracket portion each being u-shaped and configured to receive the other mount. The bracket portions have a space between the bracket portions. The other mount has a projection disposable in the space between the bracket portions. The projection also acts as a safety tab. The bracket portions enable horizontal positioning of the object mount relative to the wall mount to be adjustable. The projection is configured to interact with the bracket portions and limit horizontal movement of the object mount relative to the wall mount to within a set range spanning the space from a first position, where the projection abuts the first bracket portion, to a second position where the projection abuts the second bracket portion.Type: ApplicationFiled: December 16, 2010Publication date: June 21, 2012Inventor: Timothy Wayne Schneider
-
Publication number: 20120080316Abstract: A separation module operates to fractionate or separate an analyte into fractions according to pI, i.e., pI bands, utilizing capillary isoelectric focusing (“CIEF”) within a first microchannel. The fractions are stacked to form plugs, the number of which is determined by a number of parallel second microchannels integrally connected to the first microchannel, into which the fractions are directed according to the buffer characteristics found in each of the individual microchannels. Within the microchannels the plugs are separated into proteins according to a different chemical property, i.e., “m/z,” utilizing capillary electrophoresis (“CE”).Type: ApplicationFiled: December 12, 2011Publication date: April 5, 2012Inventors: Thomas Wayne Schneider, James N. Baraniuk
-
Patent number: 8097472Abstract: A separation module operates to fractionate or separate an analyte into fractions according to pI, i.e., pI bands, utilizing capillary isoelectric focusing (“CIEF”) within a first microchannel. The fractions are stacked to form plugs, the number of which is determined by a number of parallel second microchannels integrally connected to the first microchannel, into which the fractions are directed according to the buffer characteristics found in each of the individual microchannels. Within the microchannels the plugs are separated into proteins according to a different chemical property, i.e., “m/z,” utilizing capillary electrophoresis (“CE”).Type: GrantFiled: December 22, 2009Date of Patent: January 17, 2012Assignees: Science Applications International Corporation, Georgetown UniversityInventors: Thomas Wayne Schneider, James N. Baraniuk
-
Publication number: 20110269719Abstract: The present invention is related to pharmaceutical compositions that include a phosphonium antimicrobial agent. In a preferred embodiment, the present invention relates to an otic, nasal or ophthalmic composition (e.g., an aqueous ophthalmic solution) that includes a phosphonium salt compound as an antimicrobial agent. The compositions typically possess sufficient antimicrobial activity to satisfy USP preservative efficacy requirements and/or similar preservative standards (e.g., EP and JP).Type: ApplicationFiled: April 26, 2011Publication date: November 3, 2011Inventors: Masood A. Chowhan, Wesley Wehsin Han, L. Wayne Schneider
-
Publication number: 20110195132Abstract: The present invention is directed to the provision of multi-dose, self-preserved ophthalmic compositions. The compositions possess sufficient antimicrobial activity to satisfy USP preservative efficacy requirements, as well as similar preservative standards (e.g., EP and JP), without requiring the presence of conventional anti-microbial preservative agents, such as benzalkonium chloride. The compositions are effectively preserved by a balanced ionic buffer system containing zinc ions at a concentration of 0.04 to 0.9 mM, preferably 0.04 to 0.4 mM. One aspect of the balanced buffer system is limitation of the amount of buffering anions present to a concentration of 15 mM or less, preferably 5 mM or less. In a preferred embodiment, the compositions also contain borate or, most preferably, one or more borate/polyol complexes. The use of propylene glycol as the polyol in such complexes is strongly preferred.Type: ApplicationFiled: April 14, 2011Publication date: August 11, 2011Applicant: ALCON RESEARCH, LTD.Inventors: Bhagwati P. Kabra, Masood A. Chowhan, L. Wayne Schneider, Wesley Wehsin Han
-
Publication number: 20110124734Abstract: The present invention relates to methods for disinfecting or cleaning a contact lens comprising contacting a contact lens with a formulation comprising a N-halogenated amino acid and a phase transfer agent for a time sufficient to disinfect or clean the lens. This specification further discloses a formulation for disinfecting a contact lens comprising an N-halogenated amino acid and a phase transfer agent.Type: ApplicationFiled: January 31, 2011Publication date: May 26, 2011Applicant: ALCON RESEARCH, LTD.Inventors: Masood A. Chowhan, Wesley Wehsin Han, L. Wayne Schneider, David W. Stroman, Nissanke L. Dassanayake